HCPCS drug code · CMS crosswalk
Ziextenzo HCPCS Code
In short
Ziextenzo is billed under HCPCS Q5120 — Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 2 Ziextenzo NDCs under this code.
Reference
- Q5120
- Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mgBilling unit: 0.5 mg
- Labelers
- Sandoz Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Ziextenzo units and claim line
Enter the dose given to get the Q5120 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Ziextenzo NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 61314-0866-01 | Q5120 | Sandoz Inc. | 0.6 | 12 |
| 61314-0866-02 | Q5120 | Sandoz Inc. | 0.6 | 12 |
Ziextenzo: common questions
- What is the HCPCS code for Ziextenzo?
- Ziextenzo is billed under HCPCS Q5120 — Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 2 Ziextenzo NDCs under this code.
- How many Q5120 billing units are in a package of Ziextenzo?
- CMS lists 12 billing units per package, depending on the NDC, where one unit is 0.5 mg. Units to report are based on the dose given, not the package.
- Is Q5120 a CPT code?
- No. Q5120 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- Q5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Q5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Q5122Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
- Q5127Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
- Q5130Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
- Q5169Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg